Abiopharma

Flutter Entertainment PLC: Results of Annual General Meeting 2026

Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema

CORRECTING and REPLACING Karman Space & Defense Provides Operational Data Update in Connection with Launch of Secondary Offering

ANGI Investors Have Opportunity to Join Angi Inc. Fraud Investigation with the Schall Law Firm

Kentucky First Federal Bancorp Board of Directors to Consider Resumption of Quarterly Dividend

Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema

CBL Properties Announces $71.9 Million Non-Recourse Loan Secured by Hamilton Place in Chattanooga, TN

BeOne Medicines stelt norm voor langdurige ziektecontrole bij CLL met BRUKINSA-gegevens van 78 maanden op ASCO 2026

Malaga Financial Corporation Announces 88th Consecutive Quarterly Cash Dividend

BeOne Medicines definisce uno standard per il controllo della malattia a lungo termine nella LLC con i dati a 78 mesi di BRUKINSA allASCO 2026